Lamotrigin Stada

Lamotrigine, the active ingredient in Lamotrigin Stada, is an Anticonvulsant presented as an oral tablet for oral use. It is employed to control seizures in epilepsy, to stabilize mood in bipolar disorder, and to prevent migraine attacks in appropriate patients.

GNH USA supplies Lamotrigin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability and regulatory compliance across multiple markets.

Lamotrigine is used in several neurological and psychiatric conditions where it modulates neuronal excitability.

Epilepsy: reduces the frequency and severity of seizures in focal and generalized seizure types. Bipolar disorder: helps maintain mood stability and prevents depressive and manic episodes. Migraine prophylaxis: decreases the number of migraine attacks when taken regularly.

Lamotrigine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Headache - Nausea - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as agranulocytosis or aplastic anemia - Severe hepatic injury or liver failure

When prescribing lamotrigine, clinicians should observe several safety considerations.

Blood monitoring: perform baseline and periodic complete blood counts to detect hematologic abnormalities. Dose adjustments: reduce dose in patients with hepatic impairment or when combined with enzyme‑inducing agents. Discontinuation: avoid abrupt cessation to reduce risk of seizure recurrence. Pregnancy: weigh potential benefits against unknown fetal risks; consider specialist consultation. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine levels, raising risk of severe skin reactions. - Carbamazepine: reduces lamotrigine concentrations, potentially diminishing efficacy. - Strong enzyme inducers (e.g., phenytoin, phenobarbital): lower lamotrigine exposure, requiring dose adjustments.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, necessitating possible dose increase. - Serotonergic agents (e.g., SSRIs, SNRIs): monitor for additive central nervous system effects.